Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1111/cns.70287 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Hailiang Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Meningioma, Disease Models, Animal, Meningeal Neoplasms, Meninges. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Neurofibromatosis type 2 ( Nf2 ) gene inactivation is common in sporadic and Nf2 ‐related meningioma. There is currently scant literature describing the development of an intracranial meningioma model in animals. Given the role of Nf2 and other gene inactivation in meningeal cells, we used Cas9 mice here as the background host to establish a new animal model of skull base meningioma in this study.
Aims
Cas9 transgenic mice were purchased from Jackson Laboratory and raised in our institution. Subsequently, meningeal cells were obtained from the Cas9 transgenic mice, cultured in medium, and passaged in vitro. We then prepared lentivirus vector pLentiCre/gRNA, which could express the elements blocking the function of four genes: Nf2, P15 Ink4b , P16 Ink4a , and P19 Arf . We infected the meningeal cells with the lentivirus vector pLentiCre/gRNA and tested the expression of these four genes in those infected meningeal cells. Next, adeno‐associated virus vector pAAVCre/gRNA was injected in vivo into the skull base meningeal cells of the neonate Cas9 transgenic mice. These mice were observed once a week and killed 10 months later for brain inspection and pathological analysis.
Results
Twenty Cas9 transgenic mice were successfully bred. Five mice were killed so that meningeal cells could be extracted, cultured, and infected with the lentivirus vector pLentiCre/gRNA for 72 h in vitro. The gene function test showed that Nf2, P15 Ink4b , P16 Ink4a , and P19 Arf were all blocked in the infected meningeal cells, which indicated that the lentivirus vector pLentiCre/gRNA could effectively block the expression of the four genes in targeted cells. Then pAAVCre/gRNA was injected into the skull base meningeal cells of 15 mice in vivo, and nine mice were observed for 10 months so that the intracranial tumor growth could be assessed. Among these nine mice, pathological analysis showed that six mice had benign meningioma subtypes similar to human meningioma, one mouse had atypical meningioma, one mouse had malignant meningioma, and one mouse had sarcoma.
Conclusions
The Cas9 mouse model of skull base meningioma generated with the Nf2 genetic defect and the combinational loss of P15 Ink4b , P16 Ink4a , and P19 Arf could provide a new tool for investigating the pathogenesis of meningioma and the development of chemical interventions for this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Operation Center, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Pathology, Huashan Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Hailiang Tang
Zitieren
APA
Tang, H., Xu, F., Sun, D., Hua, L., Xiong, J., Xu, M., Xu, J., & Zhong, P. (2025). Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70287
Vancouver
Tang H, Xu F, Sun D, Hua L, Xiong J, Xu M, et al. Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70287
BibTeX
@article{Tang2025,
author = {Tang, Hailiang and Xu, Feng and Sun, Dan and Hua, Lingyang and Xiong, Ji and Xu, Ming and Xu, Jian and Zhong, Ping},
title = {Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1111/cns.70287}
}
EUVIMED